Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Essa Pharma (EPIX)

Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference Newswire.ca - Tue Apr 9, 7:00AM CDT

/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the...

EPIX : 6.82 (-2.29%)
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS Newswire.ca - Thu Mar 7, 7:13PM CST

/CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX), a clinical stage pharmaceutical company focused on developing novel therapies for the...

EPIX : 6.82 (-2.29%)
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023 Newswire.ca - Tue Feb 13, 6:00AM CST

/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the...

EPIX : 6.82 (-2.29%)
ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference Newswire.ca - Tue Feb 6, 7:00AM CST

/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the...

EPIX : 6.82 (-2.29%)
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium Newswire.ca - Thu Jan 25, 9:00AM CST

Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in patients with mCRPC Phase 2 dose...

EPIX : 6.82 (-2.29%)
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023 Newswire.ca - Tue Dec 12, 2023

/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company, focused on developing novel therapies for the...

EPIX : 6.82 (-2.29%)
U.S. CPI, Fed Decision in News Next Wee Baystreet - Fri Dec 8, 2023

Monday U.S. Featured Earnings Oracle Corporation (NYSE:ORCL) (Q2) Reported EPS for $1.05, ...

TCL-A.TO : 13.88 (-0.36%)
DOL.TO : 118.76 (+0.76%)
ORCL : 117.93 (-0.35%)
CASY : 329.86 (+2.06%)
BLBD : 37.11 (+1.20%)
JCI : 64.46 (+1.70%)
PLAB : 29.02 (-0.03%)
EPIX : 6.82 (-2.29%)
ADBE : 492.27 (-0.27%)
LEN : 161.10 (+0.04%)
NDSN : 272.06 (+0.52%)
COST : 771.31 (+1.96%)
ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference Newswire.ca - Tue Nov 21, 2023

/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the...

EPIX : 6.82 (-2.29%)
ESSA Pharma to Present at the Jefferies London Healthcare Conference Newswire.ca - Wed Nov 8, 2023

/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the...

EPIX : 6.82 (-2.29%)
ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement Newswire.ca - Mon Nov 6, 2023

/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the...

EPIX : 6.82 (-2.29%)

Barchart Exclusives

2 Standout Growth Stocks to Buy Now Barchart - 42 minutes ago
As technological advancements shape the advertising landscape, here are two growth stocks from the software space that investors might consider now. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot